Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Spravato
Recent news which mentions Spravato
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
July 23, 2024
Tickers
JNJ
NEWS
Tags
Market News
Spravato
Ketamine
From
Benzinga
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
Tickers
ABBV
AMGN
CURLF
JAZZ
Tags
cannabis rescheduling
Joe Biden
Emerging Markets
From
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Tickers
JNJ
Tags
Earnings
JNJ
News
From
Benzinga
Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year
July 20, 2023
Tickers
JNJ
Tags
Benzinga
Markets
FDA
From
Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
July 22, 2022
Tickers
DELCF
NAD
Tags
Cannabis
KWC
Spravato
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.